- Corporate Officers - P
- Pfizer Inc
Insider Trading History of Pfizer Inc
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Pfizer Inc since 2008.
The trader's CIK number is 78003.
At the time of the last reporting, Pfizer Inc was the 10% Owner of Cerevel Therapeutics Holdings, Inc.. (stock ticker symbol CERE).
Also see all insider trading activities at Cerevel Therapeutics Holdings, Inc..
Note that in the past
PFIZER INC also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Encysive Pharmaceuticals Inc (ENCY) by Pfizer Inc
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2008 | ENCY | 11,183,568 | $26,281,379 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Eiger Biopharmaceuticals, Inc. (CLDN) by Pfizer Inc
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2014 | CLDN | 227,261 | $1,818,088 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Allogene Therapeutics, Inc. (ALLO) by Pfizer Inc
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2018 | ALLO | 55,556 | $1,000,008 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Rhythm Pharmaceuticals, Inc. (RYTM) by Pfizer Inc
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2017 | RYTM | 40,000 | $680,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Neoleukin Therapeutics, Inc. (AQXP) by Pfizer Inc
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2015 | AQXP | 0 | $0 | 259,927 | $7,910,098 | 0 | $0 |
2014 | AQXP | 272,727 | $2,999,997 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Synlogic, Inc. (MIRN) by Pfizer Inc
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2015 | MIRN | 714,285 | $4,999,995 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Icagen Inc (ICGN) by Pfizer Inc
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2011 | ICGN | 4,617,045 | $27,702,270 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Cerevel Therapeutics Holdings, Inc. (CERF) by Pfizer Inc
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2020 | CERF | 1,200,000 | $12,000,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Zoetis Inc. (ZTS) by Pfizer Inc
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2013 | ZTS | 0 | $0 | 99,015,000 | $0 | 0 | $0 |
Insider trading activities at 9 companies by Pfizer Inc:
1. Encysive Pharmaceuticals Inc (ENCY)
2. Eiger Biopharmaceuticals, Inc. (CLDN)
3. Allogene Therapeutics, Inc. (ALLO)
4. Rhythm Pharmaceuticals, Inc. (RYTM)
5. Neoleukin Therapeutics, Inc. (AQXP)
6. Synlogic, Inc. (MIRN)
7. Icagen Inc (ICGN)
8. Cerevel Therapeutics Holdings, Inc. (CERF)
9. Zoetis Inc. (ZTS)
Table 1. Insider trading of Encysive Pharmaceuticals Inc (ENCY) by Pfizer Inc
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2008-04-11 | ENCY | Buy | 155,499 | 2.35 | 365,422 |
2008-04-14 | ENCY | Buy | 1,232,412 | 2.35 | 2,896,168 |
2008-04-09 | ENCY | Buy | 12,628 | 2.35 | 29,675 |
2008-04-10 | ENCY | Buy | 210,794 | 2.35 | 495,365 |
2008-04-07 | ENCY | Buy | 2,203,420 | 2.35 | 5,178,037 |
2008-04-08 | ENCY | Buy | 29,407 | 2.35 | 69,106 |
2008-04-04 | ENCY | Buy | 576,170 | 2.35 | 1,353,999 |
2008-04-03 | ENCY | Buy | 1,809,663 | 2.35 | 4,252,708 |
2008-04-04 | ENCY | Buy | 576,170 | 2.35 | 1,353,999 |
2008-04-03 | ENCY | Buy | 1,809,663 | 2.35 | 4,252,708 |
2008-04-04 | ENCY | Buy | 576,170 | 2.35 | 1,353,999 |
2008-04-03 | ENCY | Buy | 1,809,663 | 2.35 | 4,252,708 |
2008-04-01 | ENCY | Buy | 175,907 | 2.35 | 413,381 |
2008-04-02 | ENCY | Buy | 6,002 | 2.35 | 14,104 |
Table 2. Insider trading of Eiger Biopharmaceuticals, Inc. (CLDN) by Pfizer Inc
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2014-02-04 | CLDN | Buy | 227,261 | 8.00 | 1,818,088 |
Table 3. Insider trading of Allogene Therapeutics, Inc. (ALLO) by Pfizer Inc
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2018-10-15 | ALLO | Buy | 55,556 | 18.00 | 1,000,008 |
Table 4. Insider trading of Rhythm Pharmaceuticals, Inc. (RYTM) by Pfizer Inc
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2017-10-10 | RYTM | Buy | 40,000 | 17.00 | 680,000 |
Table 5. Insider trading of Neoleukin Therapeutics, Inc. (AQXP) by Pfizer Inc
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2015-08-10 | AQXP | Sale | 259,927 | 30.43 | 7,910,098 |
2014-03-12 | AQXP | Buy | 272,727 | 11.00 | 2,999,997 |
Table 6. Insider trading of Synlogic, Inc. (MIRN) by Pfizer Inc
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2015-10-06 | MIRN | Buy | 714,285 | 7.00 | 4,999,995 |
Table 7. Insider trading of Icagen Inc (ICGN) by Pfizer Inc
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2011-09-02 | ICGN | Buy | 4,617,045 | 6.00 | 27,702,270 |
Table 8. Insider trading of Cerevel Therapeutics Holdings, Inc. (CERF) by Pfizer Inc
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2020-10-27 | CERF | Buy | 1,200,000 | 10.00 | 12,000,000 |
Table 9. Insider trading of Zoetis Inc. (ZTS) by Pfizer Inc
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2013-02-06 | ZTS | Sale | 99,015,000 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Pfizer Inc
(10% Owner of Cerevel Therapeutics Holdings, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.